BioCentury
ARTICLE | Company News

Phase III start for baricitinib triggers Incyte milestone

November 16, 2012 1:52 AM UTC

Incyte Corp. (NASDAQ:INCY) received a $50 million milestone payment from Eli Lilly and Co. (NYSE:LLY) under a 2009 deal granting Eli Lilly exclusive, worldwide rights to develop and commercialize bari...